A

AN2 Therapeutics
D

ANTX

3.50000
USD
-0.10
(-2.78%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
244
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
132,454,192

العنوان: AN2 Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.